91 related articles for article (PubMed ID: 4562825)
1. Inhibition of tumor growth and survival of aged mice inoculated with Moloney tumor transplants and treated with endotoxin.
Strausser HR; Bober LA
Cancer Res; 1972 Oct; 32(10):2156-9. PubMed ID: 4562825
[No Abstract] [Full Text] [Related]
2. Tumor immunity in vivo: evidence that immune destruction of tumor leaves "bystander" cells intact.
Weissman IL
J Natl Cancer Inst; 1973 Aug; 51(2):443-8. PubMed ID: 4765368
[No Abstract] [Full Text] [Related]
3. Senescent loss of resistance to murine sarcoma virus (Moloney) in the mouse.
Pazmiño NH; Yuhas JM
Cancer Res; 1973 Nov; 33(11):2668-72. PubMed ID: 4748428
[No Abstract] [Full Text] [Related]
4. Regulation of cell-mediated immunologic reactivity to Moloney Murine sarcoma virus-induced tumors. III. Further characterization of tumor-specific serum blocking factors.
Halliday WJ; Koppi TA; McKenzie IF
J Natl Cancer Inst; 1982 Oct; 69(4):939-44. PubMed ID: 6750199
[TBL] [Abstract][Full Text] [Related]
5. Studies on the growth and regression of a transplantable Moloney sarcoma.
Fefer A; McCoy JL; Glynn JP
Cancer Res; 1967 Nov; 27(11):2207-11. PubMed ID: 4864248
[No Abstract] [Full Text] [Related]
6. [Factors regulating the spontaneous regression of primary tumors induced by murine sarcoma virus, Moloney strain, in mice (BALB-c-Cb-Se). I. Age at treatment and virus doses].
Ribacchi R; Giraldo G
Lav Ist Anat Istol Patol Univ Studi Perugia; 1967; 27(3):167-76. PubMed ID: 5605880
[No Abstract] [Full Text] [Related]
7. Protective effect of immune sera against transplantable Moloney virus-induced sarcoma and lymphoma.
Pearson GR; Redmon LW; Bass LR
Cancer Res; 1973 Jan; 33(1):171-8. PubMed ID: 4734119
[No Abstract] [Full Text] [Related]
8. Growth of murine sarcoma and murine xenotropic leukemia viruses in Japanese quail: induction of tumors and development of continuous tumor cell lines.
Robey WG; Kuenzel WJ; Vande Woude GF; Fischinger PJ
Cancer Res; 1982 Jul; 42(7):2523-9. PubMed ID: 6282443
[TBL] [Abstract][Full Text] [Related]
9. Depression of antilymphoma allograft reactivity by tumor-associated factors.
Bonmassar E; Bonmassar A; Goldin A; Cudkowicz G
Cancer Res; 1973 May; 33(5):1054-61. PubMed ID: 4703118
[No Abstract] [Full Text] [Related]
10. Biologic studies on hamster tumors induced by the murine sarcoma virus (Moloney).
Perk K; Viola MV; Smith KL; Wivel NA; Moloney JB
Cancer Res; 1969 May; 29(5):1089-102. PubMed ID: 4181060
[No Abstract] [Full Text] [Related]
11. Pathogenesis of a rhabdomyosarcoma (undifferentiated type) in rats induced by a murine sarcoma virus (Moloney).
Perk K; Shachat DA; Moloney JB
Cancer Res; 1968 Jun; 28(6):1197-206. PubMed ID: 5658448
[No Abstract] [Full Text] [Related]
12. Specificity of homograft rejection in vivo, assessed by inoculation of artificially mixed compatible and imcompatible tumor cells.
Klein E; Klein G
Cell Immunol; 1972 Sep; 5(1):201-8. PubMed ID: 5078988
[No Abstract] [Full Text] [Related]
13. Immunotherapy and chemotherapy of Moloney sarcoma virus-induced tumors in mice.
Fefer A
Cancer Res; 1969 Dec; 29(12):2177-83. PubMed ID: 5369675
[No Abstract] [Full Text] [Related]
14. Stress and murine sarcoma virus (Moloney)-induced tumors.
Amkraut A; Solomon GF
Cancer Res; 1972 Jul; 32(7):1428-33. PubMed ID: 4337829
[No Abstract] [Full Text] [Related]
15. T cell tolerance in moloney-murine leukemia virus (M-MuLV) carrier mice: low cytotoxic T lymphocyte precursor frequency and absence of suppressor T cells in carrier mice with Moloney-murine sarcoma (M-MSV)-induced tumors.
Collavo D; Ronchese F; Zanovello P; Biasi G; Chieco-Bianchi L
J Immunol; 1982 Feb; 128(2):774-9. PubMed ID: 6459385
[No Abstract] [Full Text] [Related]
16. Enhancement of murine sarcoma virus (Moloney) infection and tumorigenesis in vivo by coinfection with Rauscher leukemia virus.
Turner W; Chirigos MA
Cancer Res; 1969 Nov; 29(11):1956-60. PubMed ID: 5358213
[No Abstract] [Full Text] [Related]
17. Tumor sponge implantation: an in vivo method for studying syngeneic, primary antitumor lymphocyte responses.
Vallera DA; Mentzer SJ; Maizel SE
Cancer Res; 1982 Feb; 42(2):397-404. PubMed ID: 7055792
[TBL] [Abstract][Full Text] [Related]
18. The age related responses of New Zealand mice to a murine sarcoma virus.
Gazdar AF; Beitzel W; Talal N
Clin Exp Immunol; 1971 Mar; 8(3):501-9. PubMed ID: 5576664
[TBL] [Abstract][Full Text] [Related]
19. Tumour regression and relapse in mice inoculated with murine sarcoma virus (Moloney).
Perk K; Russell E; Smith KL; Moloney JB
Lab Anim; 1973 Sep; 7(3):255-63. PubMed ID: 4795193
[No Abstract] [Full Text] [Related]
20. Recognition of H-2Kb mutant target cells by Moloney virus-specific cytotoxic T lymphocytes from bm13 (H-2Db-mutant) mice. II. Relationship of Kbm3 and Kbm11 in restriction specificities and allodeterminants.
Stukart MJ; Boes J; Melief CJ
J Immunol; 1984 Jul; 133(1):28-32. PubMed ID: 6202783
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
